Media Centre
Latest press releases
-
Faslodex (fulvestrant) receives positive CHMP opinion for use in 1st-line hormone receptor-positive advanced breast cancer
-
AstraZeneca presents new data underpinning safety profile and real-world CV outcomes of Farxiga at ADA 2017
-
AstraZeneca to present scientific advances in cardiovascular and metabolic diseases at 2017 ADA Scientific Sessions
-
AstraZeneca enters agreement with Grünenthal to divest rights to migraine treatment Zomig
-
Lynparza significantly reduces the risk of disease worsening or death in patients with BRCA-mutated metastatic breast cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Esra Erkal-Paler
Global Head of External Communications
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
